A Novel NanoDisc Platform for Systemic Targeting of Lymphoid Tissues and Induction of Antigen-Specific Immune Tolerance
Time: 12:00 pm
day: Day Two
Details:
- Exploring how subcutaneous administration of NanoDisc targets multiple lymphoid tissues and immune system organs
- NanoDisc carrying autoantigen induces antigen-specific Tregs and Tr1 cells
- NanoDisc therapy exerts robust efficacy in preclinical models of Multiple Sclerosis and Type 1 Diabetes
